Patent · US Expired

Transdermal therapeutic system and a process for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins in particular soman

US5939095A · kind A · utility

4Cited by

9References

6Claims

0Family size

Assignee

LTS Lohmann Therapie-Systeme AG · DE

Inventors

Thomas Hille · Neuwied, DE
Walter Muller · Neuwied, DE
Bodo Asmussen · Bendorf, DE

Key dates

Filing date	Jul 30, 1996
Grant date	Aug 17, 1999
Priority date	—
Expiry date	Jul 30, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A transdermal therapeutic system for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins is characterized in that it has a pharmaceutical formulation with an active substance combination consisting of at least one parasympathomimetically active substance and at least one parasympatholytically active substance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.